Diana Stefani-hunyady MD, MBA, BCMAS

Diana brings with her over 22 years of extensive and diverse experience in clinical research, academia, and the biopharmaceutical industry. A Medical Doctor trained in Europe, Diana specialized in Internal Medicine and Gastroenterology. Specialization within GI and hepatology include Barrett’s esophagitis, IBD, IBS, eso -gastric and intestinal motility, chronic hepatitis, and rare GI diseases. She also holds an MBA degree in Global Management, earned in the US.

Prior to transitioning to the biopharmaceutical industry in 1994, Diana was Professor Assistant and staff principal in a University Hospital setting. She continued to evolve in roles of increasing responsibility, in Europe, then in the US and globally, at various stages of product life-cycle, in companies such as Schering-Plough, Bayer, Agenus, Onyx Pharmaceuticals, and the Shire.

In addition to her original fields of specialization, Diana gained expertise in Oncology, Immuno-oncology, Rare Diseases, Cardio-vascular surgery and anticoagulation, Diabetes, and Anti-Infectives. Diana also held a CME speaker position for the Agency of Healthcare Research and Quality (AHRQ) in the US, working on the Comparative Effectiveness and Patient-Centered Outcomes Programs and KOL management systems. She also chaired the first Patient Registries Summit in Orlando in early 2016.